Today’s Headlines: FDA Approves New Breast Cancer Drug, Mediterranean Diet News and More

FDA Approves New Breast Cancer Medication: The FDA just approved a new cancer drug, Kadcyla, that can treat certain breast cancer patients. Considered a “smart-bomb” new cancer drug, Kadcyla works by targeting specific tumor cells and delivering special toxins that would specifically kill tumor cells, leaving healthy cells alone and minimizing side effects. If utilized regularly, the drug would cost $9,800 a month and $94,000 for a typical course of treatment. (New York Times)

Mediterranean Diet Linked to Reduced Heart Risks: According to a recently published study in the New England Journal of Medicine, “about 30 percent of heart attacks, strokes and deaths from heart disease can be prevented in people at high risk if they switch to a diet rich in olive oil, nuts, fish, fruits and vegetables.” The heart-healthy effects of the Mediterranean diet come as no surprise. However, the sheer magnitude of the diet’s benefits was so obvious that the study was terminated early because it was considered unethical for the researchers to continue. (New York Times)

Smiling Linked to Certain Health Benefits: Various research studies point to lower stress and heart rate as some of the health benefits of smiling. Even though a full and genuine smile has been shown to affect the body in positive ways, some of the reported studies indicate that even a polite smile or forced smile may be beneficial as well. (Wall Street Journal)